Newspace Research & Technologies

NewSpace Research and Technologies (NRT) is a drone manufacturer in India's defense sector, developing next-generation aerospace solutions.

Headquarters

Year Founded

Search Tags

Persistent Drone Technology, High-Altitude UAV Systems, Aerospace Unmanned Platforms

About Us

NewSpace Research and Technologies develops advanced unmanned aerospace systems specializing in high-altitude persistent drones for earth observation and communications. The company creates intelligent cyber-physical uncrewed systems capable of operating at altitudes between 5-20 kilometers with extended endurance ranging from days to months. Their High Altitude Pseudo Satellite (HAPS) UAV represents cutting-edge aerospace technology, designed to perform complex missions with dynamic retasking capabilities and advanced intelligent mesh network integration.

Trending Companies

Latest Articles

Engineer intelligent, AI-driven supply chain operations. Discover what next-generation leaders must master to design resilient, data-driven, high-performing global networks.

The Future of Supply Chain Leadership: Why the Next Generation Will Engineer Intelligence, Not Just Manage It

Supply chain leadership is being redefined by AI, intelligent automation, and agentic decision-making, demanding leaders who can engineer end-to-end intelligence rather than simply manage workflows. This article explores how next-generation supply chain leaders will combine data, algorithms, and human judgment to build resilient, adaptive, and high-performing global operations.

Read More >
Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >